Q3 2024 Holdings
Filed 2024-11-14 | 63 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $147.5M | 810,245 | 8.7% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $96.2M | 4,280,981 | 5.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $88.1M | 8,246,592 | 5.2% |
| Immunome Inc(IMNM) | COM | 45257U108 | $71.5M | 4,889,554 | 4.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $65.9M | 1,393,256 | 3.9% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $64.0M | 5,101,911 | 3.8% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $57.9M | 4,713,509 | 3.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $52.4M | 4,781,183 | 3.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $51.7M | 1,034,219 | 3.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $51.3M | 4,892,902 | 3.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $50.8M | 3,072,478 | 3.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $49.4M | 15,669,217 | 2.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $48.4M | 4,484,380 | 2.9% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $46.1M | 13,169,057 | 2.7% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $46.0M | 875,039 | 2.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $42.0M | 5,238,837 | 2.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $40.5M | 964,347 | 2.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $39.8M | 1,387,479 | 2.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $39.5M | 1,611,013 | 2.3% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $38.5M | 16,380,327 | 2.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $38.1M | 6,427,462 | 2.2% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $36.1M | 595,570 | 2.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $35.8M | 3,197,491 | 2.1% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $34.5M | 1,899,317 | 2.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $32.1M | 552,506 | 1.9% |
| Absci Corporation(ABSI) | COM | 00091E109 | $31.5M | 8,253,316 | 1.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $27.7M | 330,873 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $22.3M | 657,175 | 1.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $21.6M | 681,150 | 1.3% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $19.6M | 5,615,489 | 1.2% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $18.3M | 154,456 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $18.3M | 642,229 | 1.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $13.6M | 1,262,090 | 0.8% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $13.1M | 26,698 | 0.8% |
| Stryker Corporation(SYK) | COM | 863667101 | $11.8M | 32,741 | 0.7% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $11.6M | 1,569,850 | 0.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $11.4M | 1,660,763 | 0.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $11.3M | 261,803 | 0.7% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $10.1M | 411,728 | 0.6% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $8.0M | 2,074,350 | 0.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $7.0M | 3,836,576 | 0.4% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $6.9M | 3,031,009 | 0.4% |
| Verve Therapeutics Inc | COM | 92539P101 | $6.7M | 1,383,366 | 0.4% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $6.7M | 1,942,555 | 0.4% |
| AC Immune SA(ACIU) | SHS | H00263105 | $6.4M | 1,694,167 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $5.1M | 97,116 | 0.3% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $4.6M | 2,107,215 | 0.3% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $4.3M | 2,108,219 | 0.3% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $3.7M | 452,270 | 0.2% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $3.6M | 1,023,548 | 0.2% |